Hjem › Ikke-småcellet lungekreft › Alabama › Mobile
Kliniske studier for Ikke-småcellet lungekreft i Mobile, AL
13 studier for Ikke-småcellet lungekreft søker deltakere på steder i og rundt Mobile (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.
RekruttererFase 2/3
- Southern Cancer Center, P.C., Daphne · 10 mi unna
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
RekruttererFase 3
- Southern Cancer Center Pc, Daphne · 10 mi unna
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
RekruttererFase 3
- Southern Cancer Center Pc, Daphne · 10 mi unna
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
RekruttererFase 3
- Southern Cancer Center, Daphne · 10 mi unna
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
RekruttererFase 2
- Southern Cancer Center, PC, Daphne · 10 mi unna
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
RekruttererFase 3
- Infirmary Cancer Care, Mobile
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
RekruttererFase 3
- Local Institution - 0487, Mobile
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
RekruttererFase 2
- Mobile Infirmary Medical Center, Mobile
- Gulf Health Hospitals Inc/Infirmary Cancer Care - Saraland, Saraland · 9 mi unna
- Gulf Health Hospitals Inc/Infirmary Cancer Care - Malbis, Daphne · 10 mi unna
- og 1 flere
MYLUNG Consortium Part 3: Observational Study
RekruttererObservasjonsstudie
- Southern Cancer Center, PC, Daphne · 10 mi unna
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
RekruttererFase 2/3
- Mobile Infirmary Medical Center, Mobile
- Gulf Health Hospitals Inc/Infirmary Cancer Care - Saraland, Saraland · 9 mi unna
- Gulf Health Hospitals Inc/Infirmary Cancer Care - Malbis, Daphne · 10 mi unna
- og 1 flere
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
RekruttererFase 2
- Mobile Infirmary Medical Center, Mobile
- Gulf Health Hospitals Inc/Infirmary Cancer Care - Saraland, Saraland · 9 mi unna
- Gulf Health Hospitals Inc/Infirmary Cancer Care - Malbis, Daphne · 10 mi unna
- og 1 flere
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Rekrutterer
- University of South Alabama, Mobile
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruttererObservasjonsstudie
- Massive Bio SYNERGY-AI site, Mobile
Ikke-småcellet lungekreft-studier i andre byer
- Houston, TX145 studier
- New York City, NY121 studier
- Arlington, VA104 studier
- Nashville, TN97 studier
- Boston, MA90 studier
- Los Angeles, CA87 studier
- St. Louis, MO73 studier
- Chicago, IL61 studier
- Baltimore, MD60 studier
- San Antonio, TX59 studier
- Columbus, OH57 studier
- Washington, DC55 studier
Andre studier i Mobile
- Hjertesvikt13 studier
- Fedme7 studier
- Lungekreft7 studier
- Brystkreft7 studier
- Eggstokkreft7 studier
- Melanom6 studier
- Kreft (alle typer)6 studier
- Småcellet lungekreft6 studier
- Kardiovaskulær sykdom6 studier
- Crohns sykdom5 studier
- Overvekt5 studier
- Type 2-diabetes5 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.